What is Clin-Path?
Incorporated in 1974, Clin-Path operates as a physician-owned pathology practice that has evolved into a critical component of the regional healthcare infrastructure. The firm is currently comprised of 7 pathologists and 27 board-certified physicians, offering a comprehensive suite of diagnostic expertise. Their core competencies span pediatric pathology, cytopathology, dermatopathology, and hematopathology. By maintaining a physician-led governance model, Clin-Path ensures that clinical excellence remains the primary driver of its diagnostic workflows, distinguishing it from larger, corporate-owned laboratory conglomerates.
How much funding has Clin-Path raised?
Clin-Path has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
Key Investors in Clin-Path
PPP
Public-Private Partnership
What's next for Clin-Path?
The infusion of capital represents a strategic pivot toward enhancing the firm's diagnostic throughput and technological integration. As the healthcare landscape shifts toward more personalized medicine, Clin-Path is well-positioned to leverage its deep clinical expertise to expand its service offerings. Future growth initiatives will likely focus on scaling its dermatopathology and hematopathology divisions, ensuring that the practice remains at the forefront of medical diagnostics in Arizona. By prioritizing physician-led innovation, the firm is poised to navigate the complexities of modern healthcare delivery while maintaining the high standards of care that have defined its five-decade history.
See full Clin-Path company page
